Notably, IFN-γ-induced chemokine expression, such as CXCL9 and CXCL10, is significantly elevated in the lesional skin and plasma of vitiligo patients, often serving as biomarkers of clinical activity (97, 98). This evidence concerns the gene CXCL10 and vitiligo.